Liht Cannabis Corp. (C:LIHT*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 102-1561 Sutherland Ave
Tel: N/A
IR: See website
Key People
Linda Sampson
President, Chief Operating Officer, Director
Hanspaul Pannu
Rahim Mohamed
Chief Executive Officer, Director
Nilda Rivera
Chief Financial Officer
Business Overview
Liht Cannabis Corp, formerly Marapharm Ventures Inc is a Canada-based company, which focuses on the health industry, including medical and recreational cannabis products. It engages in the field of maximizing the purity and yield of cannabis, as well as in the development of a prescribed dosage formula for medical patients. The Company has the following projects, which are operated under the Company and its subsidiaries: California includes two industrial properties in Desert Hot Springs; Canada project owns parcel of land in Kelown; Las Vegas is constructing Cannabis cultivation facility in the Apex business park, situated within the city of North Las Vegas, Nevada; Marapharm.TV is a broadcasting channel with programs on the cannabis industry and providing weekly market reports of the Company's stock activity and updates on its operations; Washington State owns approximately 13.6 acres of industrial land and buildings.
Financial Overview
For the nine months ended 31 December 2018, Liht Cannabis Corp revenues increased 97% to C$1M. Net loss applicable to common stockholders decreased 56% to C$3.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Share ofgain (loss) in equity investment increase from C$767K (expense) to C$1.4M (income).
Reporting Currency: Canadian Dollars
Enterprise value: $47.87M as of Dec 31, 2018
Annual revenue (TTM): $0.67M as of Dec 31, 2018
EBITDA (TTM): -$9.14M as of Dec 31, 2018
Net annual income (TTM): -$16.46M as of Dec 31, 2018
Free cash flow (TTM): -$24.01M as of Dec 31, 2018
Net Debt Last Fiscal Year: $4.67M as of Dec 31, 2018
Shares outstanding: 236,776,132 as of Mar 7, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization